(Reuters) -Drugmaker Bristol Myers (NYSE:BMY) Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and.
By Sam Nussey TOKYO (Reuters) -Microsoft backed artificial intelligence startup OpenAI made a pitch for business in Japan on Monday as it opened its first Asia office in Tokyo. “This.
MADRID (Reuters) -Spanish drug maker Grifols, battling a plunge in its share price this year, plans to add independent directors to its audit and compensation committees to improve its governance,.
(Reuters) – Apple (NASDAQ:AAPL)’s smartphone shipments dropped about 10% in the first quarter of 2024, hurt by intensifying competition by Android smartphone makers aiming for the top spot, data from.
By Leah Douglas and Alexandra Alper (Reuters) -The Biden administration will award up to $6.4 billion in grants to South Korea’s Samsung to expand its chip production in central Texas.
BEIJING (Reuters) – Intel (NASDAQ:INTC) will release two AI chips with reduced capabilities for the Chinese market, in order to comply with U.S. export controls and sanctions. The two chips,.
| SHANGHAI/BERLIN (Reuters) – Tesla (NASDAQ:TSLA)’s global job cuts include reducing staff in the U.S. and China, the automakers’ two biggest markets, across sales, tech, and engineering, five sources briefed.
By Selena Li HONG KONG (Reuters) – HSBC plans to accelerate the expansion of its wealth business in China despite economic headwinds and is on track to nearly double its.
By Tatiana Bautzer and Saeed Azhar NEW YORK (Reuters) – Citigroup investors have rewarded CEO Jane Fraser with a share price boost after Fraser announced a sweeping overhaul of Citi’s.
TOKYO (Reuters) – Microsoft Corp (NASDAQ:MSFT) will invest about $2.9 billion over the next two years to boost its artificial intelligence (AI) business in Japan, the Nikkei newspaper reported on Tuesday citing the company.
